Zepbound 2.5 mg/0.5 mL injection Images
Generic Name: tirzepatide
This medication has been identified as Zepbound 2.5 mg/0.5 mL injection. It is supplied by Eli Lilly and Company.
Zepbound is used in the treatment of Weight Loss (Obesity/Overweight) and belongs to the drug class Incretin Mimetics (GLP-1 Agonists). Zepbound 2.5 mg/0.5 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Zepbound
- Generic Name
- tirzepatide
- Strength
- 2.5 mg/0.5 mL injection
- Availability
- Prescription only
- Drug Class
- Incretin Mimetics (GLP-1 Agonists)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-2506
More about Zepbound (tirzepatide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (128)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: Incretin Mimetics (GLP-1 Agonists)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
